Threatening Life Events and Difficulties and Psychotic Disorder.


Journal

Schizophrenia bulletin
ISSN: 1745-1701
Titre abrégé: Schizophr Bull
Pays: United States
ID NLM: 0236760

Informations de publication

Date de publication:
08 07 2020
Historique:
pubmed: 13 2 2020
medline: 18 5 2021
entrez: 13 2 2020
Statut: ppublish

Résumé

Stressful life events have been implicated in the onset of psychotic disorders, but there are few robust studies. We sought to examine the nature and magnitude of associations between adult life events and difficulties and first-episode psychoses, particularly focusing on contextual characteristics, including threat, intrusiveness, and independence. This study forms part of the Childhood Adversity and Psychosis Study (CAPsy), an epidemiological case-control study in London, United Kingdom. Data on life events and difficulties (problems lasting 4 wk or more) during 1 year prior to onset (cases) or interview (controls) were assessed using the semi-structured Life Events and Difficulties Schedule (LEDS). Data were available on 253 individuals with a first episode of psychosis and 301 population-based controls. We found strong evidence that odds of exposure to threatening and intrusive events in the 1 year prior to onset were substantially higher among cases compared with controls, independent of age, gender, ethnicity, and social class (ORs > 3). This was consistent across diagnostic categories. We found further evidence that the effect of threatening events and difficulties was cumulative (1 event odds ratio [OR] 2.69 [95% confidence interval (CI) 1.51-4.79]; 2 events OR 4.87 [95% CI 2.34-10.16]; ≥3 events OR 5.27 [95% CI 1.83-15.19]; 1 difficulty OR 3.02 [95% CI 1.79-5.09]; 2 difficulties OR 9.71 [95% CI 4.20-22.40]; ≥3 difficulties OR 12.84 [95% CI 3.18-51.85]). Threatening and intrusive life events and difficulties are common in the year pre-onset among individuals with a first episode of psychosis. Such experiences may contribute to the development of psychotic disorders.

Identifiants

pubmed: 32047940
pii: 5734535
doi: 10.1093/schbul/sbaa005
pmc: PMC7342097
doi:

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

814-822

Subventions

Organisme : Medical Research Council
ID : G108/603
Pays : United Kingdom
Organisme : MRF
ID : MRF_C0439
Pays : United Kingdom
Organisme : Wellcome Trust
ID : WT087417
Pays : United Kingdom

Informations de copyright

© The Author(s) 2020. Published by Oxford University Press on behalf of the Maryland Psychiatric Research Center.

Références

Epidemiol Psichiatr Soc. 2009 Jul-Sep;18(3):221-8
pubmed: 20034200
Arch Gen Psychiatry. 1991 Aug;48(8):764-70
pubmed: 1883262
Early Interv Psychiatry. 2019 Dec 30;:
pubmed: 31889426
Psychol Med. 2001 Feb;31(2):189-95
pubmed: 11232907
Soc Psychiatry Psychiatr Epidemiol. 2014 Oct;49(10):1541-4
pubmed: 25189139
Schizophr Bull. 1982;8(3):470-84
pubmed: 7134891
Schizophr Res. 2013 Oct;150(1):169-75
pubmed: 23891482
Arch Gen Psychiatry. 2003 Aug;60(8):789-96
pubmed: 12912762
Br J Psychiatry. 2014;204:346-53
pubmed: 24627297
Psychol Med Monogr Suppl. 1992;20:1-97
pubmed: 1565705
Psychosom Med. 2017 Feb/Mar;79(2):162-171
pubmed: 27428857
Elife. 2019 Nov 12;8:
pubmed: 31711569
Schizophr Res. 2005 Dec 1;80(1):117-30
pubmed: 15978778
Br J Psychiatry. 2011 Jul;199(1):29-37
pubmed: 21508437
JAMA Psychiatry. 2019 Jun 1;76(6):584-593
pubmed: 30892562
Schizophr Bull. 2014 Mar;40 Suppl 2:S123-30
pubmed: 24562491
Psychiatry Res. 2012 Apr 30;196(2-3):323-4
pubmed: 22390830
Schizophr Bull. 2013 Jul;39(4):740-7
pubmed: 23671196
Psychol Med. 1994 May;24(2):503-13
pubmed: 8084944
Am J Psychiatry. 2011 Jan;168(1):65-72
pubmed: 20952460
Psychol Med. 2013 Dec;43(12):2673-84
pubmed: 23531413
Psychother Psychosom. 2007;76(6):361-8
pubmed: 17917472
Schizophr Bull. 2008 Jan;34(1):193-9
pubmed: 17586579
Acta Psychiatr Scand. 1985 Mar;71(3):211-6
pubmed: 3984763
J Health Soc Behav. 1968 Sep;9(3):203-14
pubmed: 5676853
Schizophr Bull. 2018 Feb 15;44(2):348-358
pubmed: 28535284
Psychol Med. 2003 Oct;33(7):1169-75
pubmed: 14580071
Cult Med Psychiatry. 1987 Jun;11(2):123-205
pubmed: 3595169
Psychol Med. 1973 Feb;3(1):74-87
pubmed: 4692493
Psychol Med. 2011 Jun;41(6):1127-31
pubmed: 20810003
Acta Psychiatr Scand. 2020 Jan;141(1):43-51
pubmed: 31618440
Psychol Med. 2007 Oct;37(10):1377-91
pubmed: 17335638
Soc Psychiatry Psychiatr Epidemiol. 1995 Jan;30(1):1-4
pubmed: 7892612
Acta Psychiatr Scand. 2007 Oct;116(4):280-9
pubmed: 17803758
Schizophr Bull. 2010 Jul;36(4):655-64
pubmed: 20513653
Br J Psychiatry. 2009 Dec;195(6):488-91
pubmed: 19949195
Br J Psychiatry. 1993 Jan;162:72-9
pubmed: 8425143

Auteurs

Stephanie Beards (S)

Social Epidemiology Research Group, Health Service and Population Research Department, Institute of Psychiatry, Psychology & Neuroscience, King's College London, London, UK.

Helen L Fisher (HL)

MRC Social, Genetic & Developmental Psychiatry Centre, Institute of Psychiatry, Psychology & Neuroscience, King's College London, London, UK.
ESRC Centre for Society and Mental Health, King's College London, London, UK.

Charlotte Gayer-Anderson (C)

Social Epidemiology Research Group, Health Service and Population Research Department, Institute of Psychiatry, Psychology & Neuroscience, King's College London, London, UK.
ESRC Centre for Society and Mental Health, King's College London, London, UK.

Kathryn Hubbard (K)

Social Epidemiology Research Group, Health Service and Population Research Department, Institute of Psychiatry, Psychology & Neuroscience, King's College London, London, UK.

Ulrich Reininghaus (U)

Social Epidemiology Research Group, Health Service and Population Research Department, Institute of Psychiatry, Psychology & Neuroscience, King's College London, London, UK.
Central Institute of Mental Health, Medical Faculty Mannheim, University of Heidelberg, Mannheim, Germany.

Thomas J Craig (TJ)

Social Epidemiology Research Group, Health Service and Population Research Department, Institute of Psychiatry, Psychology & Neuroscience, King's College London, London, UK.

Marta Di Forti (M)

MRC Social, Genetic & Developmental Psychiatry Centre, Institute of Psychiatry, Psychology & Neuroscience, King's College London, London, UK.

Valeria Mondelli (V)

Psychosis Studies Department, Institute of Psychiatry, Psychology & Neuroscience, King's College London, London, UK.

Carmine Pariante (C)

Psychosis Studies Department, Institute of Psychiatry, Psychology & Neuroscience, King's College London, London, UK.

Paola Dazzan (P)

Psychosis Studies Department, Institute of Psychiatry, Psychology & Neuroscience, King's College London, London, UK.

Robin Murray (R)

Psychosis Studies Department, Institute of Psychiatry, Psychology & Neuroscience, King's College London, London, UK.

Craig Morgan (C)

Social Epidemiology Research Group, Health Service and Population Research Department, Institute of Psychiatry, Psychology & Neuroscience, King's College London, London, UK.
ESRC Centre for Society and Mental Health, King's College London, London, UK.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH